Research shows that the drug Imatinib, usually prescribed for Leukemia and gastric cancer, halves mortality and shortens the stay of Covid patients at the ICU by a week. Imatinib is especially effective in the 20 percent most ill Covid patients. However, further research is needed. Follow-up studies will be done by Amsterdam OLVG, the Erasmus Medical Center, the Dijklander Hospital and by the World Health Organisation in the Remapcap study.
Read more (in Dutch)
Kepler Vision Technologies, a spin-off company from the University of Amsterdam, secured a significant €1.5M investment from ROM InWest last month. The Dutch company will use the funds to accelerate the production of its ‘Kepler Night Nurse’ solution, a smart technology for care home fall detection. The company is now positioned for global expansion, targeting the UK and US markets.
NewsUvA Ventures Holding has launched the Social Sciences & Humanities (SSH) Impact Fund that aims to capitalize on SSH research by supporting the development of academic spin-offs that address societal challenges. The initiative is a response to the need for practical applications of SSH research, identified through discussions with university researchers. For whom? The SSH […]
News“With this agreement, we fortify our collaboration, reaffirming our dedication to diversity, sustainability, and entrepreneurship – values exemplified by DNNL. An endeavor that aligns with the educational and research efforts we stand for as a university,” says VU President Jonkman.
News